{
    "nctId": "NCT02055937",
    "briefTitle": "Immediate Implant Breast Reconstruction",
    "officialTitle": "Immediate Implant Breast Reconstruction for Patients With Mastectomy Ans Post op\u00e9rative Chest Wall Radiotherapy",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 53,
    "primaryOutcomeMeasure": "Success is defined as a complete therapeutic sequence (surgery + RT) without any significant complication at 6 months.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed breast carcinoma\n* Patients planned for mastectomy with immediate single stage breast reconstruction using an acellular dermal matrix (Strattice\u2122, LifeCell Corporation)\n* Patients planned to receive postoperative chest wall irradiation\n* Age \u2265 18 years old\n* WHO performance status 0-1\n* Affiliation to a social security system\n* Informed consent signed prior any study specific procedures\n\nExclusion Criteria:\n\n* Inflammatory breast cancer\n* Tumors with extensive involvement of the skin\n* Use of tissue expander\n* Indication of postoperative chemotherapy\n* Patients planned for bilateral mastectomy\n* History of previously treated ipsilateral breast carcinoma\n* Usual contraindications for ADM\n* Medical debility precluding surgical treatment\n* Psychological, social, geographical disorders or any other condition that would preclude study compliance (treatment modalities and study follow-up).\n* Pregnancy or breast feeding\n* Inability to attend or comply with interventions or follow-up scheduling, disability or difficulty preventing a proper understanding of trial instructions\n* Legal inability or restricted legal ability",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}